CARTA AO EDITOR
Risco de desenvolver câncer em receptores de sangue violetado. Validade da entrevista
Prof. Vicente Amato Neto; Dr. Jacyr Pasternak
Universidade de São Paulo
Texto completo disponível apenas em PDF.
Full text available only in PDF format.
- 1. Blumberg N, Heal JM, Murphy P, Agarwal MM, Chuang C. Association between transfusions of whole blood and recurrense of cancer. British Medical Journal 293:530-533, 1986.
- 2. Gascon P, Zoumbs NC, Young Ns. Immunologic abnormalities in patients receiving multiple blood transfusions. Annals of Internal Medicine 100:173-177, 1984.
- 3. Hamblin T. Blood transfusions and cancer: anomalies explained? British Medical Journal 293:517-518, 1986.
- 4. Kaplan BJ, Samaik S, Gitlin J, Lusher J. Diminished helper/supressor lymphocyte rations and natural killer activity in recipients of repeated blood transfusion. Blood The Journal of the American Society of Hematology 64:308-310, 1984.
- 5. Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer. International Journal of Cancer 41:677-682, 1988.
- 6. Stevens R, Jones Y, Micozzi M, Taylor PR. Body iron stores and the risk of cancer. The New England Journal of Medicine 319:1047-1052, 1988.
- 7. Stevens RG, Beasley RP, Blumberg BS. Iron binding proteins and risk of cancer in Taiwan. Journal of the National Cancer Institute 76:605-610, 1986.
Datas de Publicação
-
Publicação nesta coleção
27 Maio 2013 -
Data do Fascículo
Mar 1990
